1. Versatile use to fill the gap and achieve anatomical correction of the biological system as and when necessary
2. Time can be saved during procedures through the rinseless and ready to use preparation due to its non glutaraldehyde treated nature.
3. Our processing methodology incorporates an anti-calcification treatment of a proprietary nature.
4. Suturability and reliable handling are achieved in SynkroScaff
5. Cytotoxicity and antigenicity are absent through the proprietary technology. Aneurysm formation and patch shrinkage have not been reported so far.
6. SynkroScaff can be sutured or stapled to the host tissue/blood vessel.
7. Advantages of using SynkroScaff : Compared to synthetic or other available bovine pericardial patches, suturability and easy handling are provided for the surgeons. It has got extracellular matrix intact but without any bovine cells and it integrates with the system. Cytotoxicity, antigenicity are absent through the proprietary technology. Our processing methodology incorporates an anti-calcification treatment of a proprietary nature. No Thrombogenicity.
Our device, SynkroScaff, is a biological patch of Tissue engineered Bovine Pericardium that has been preserved in a buffered solution with a shelf life of two year.
SynkroScaff is currently available in 2x2 cm, 4x4 cm, 6x6 cm, 8x8 cm. Thickness varies from 0.3mm to 0.5mm.
Yes, SynkroScaff is supplied sterile in consecutive two gamma sterilised packs apart from the gamma sterilised container.
SynkroScaff is supplied in a sterile and non-pyrogenic, sealed container and is designed to facilitate convenient, aseptic transfer of the pericardium to the sterile field.
Yes, SynkroScaff may be tailored during surgery to meet the specific configuration.
No, Any unused portion of the tissue must be disposed of as a biological waste as per hospital norms.
No, the patches cannot be re-sterilized.
As our Product is Non-Glutraldehyde based bovine pericardial patches, suturability and easy handling are provided for the surgeons. It has got extracellular matrix intact but without any Acellular and it integrates with the system. Cytotoxicity, antigenicity are absent through the proprietary technology Our processing methodology incorporates an anti-calcification treatment of a proprietary nature. No Thrombogenici1y.